Product Description: Zelicapavir (RSV-IN-7) (example 253) is an orally active RSV inhibitor (EC50: [1].
Applications: COVID-19-anti-virus
Formula: C27H22F3N7O3
References: [1]Shook Brian C., et al. Preparation of benzodiazepine derivatives for use as RSV inhibitors. Patent. WO2017015449 A1. /[2]Rhodin MHJ, et al., EDP-938, a novel nucleoprotein inhibitor of respiratory syncytial virus, demonstrates potent antiviral activities in vitro and in a non-human primate model. PLoS Pathog. 2021 Mar 15;17(3):e1009428.
CAS Number: 2070852-76-3
Molecular Weight: 549.50
Compound Purity: 99.10
Research Area: Infection
Solubility: DMSO : 50 mg/mL (ultrasonic)
Target: RSV